Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Aringer

Showing results (11-20 of 216) with videos related to

Pageof 22
Sort By:
The Lancet. Rheumatology|January 30, 2024
Who will respond to type I interferon receptor blockade in SLE?Martin Aringer
Deutsche Medizinische Wochenschrift (1946)|March 30, 2016
[Systemic lupus erythematosus]Martin Aringer, Matthias Schneider
Deutsche Medizinische Wochenschrift (1946)|May 29, 2018
[Systemic Lupus Erythematosus (SLE) - New Classification Criteria]Martin Aringer, Thomas Dörner
Zeitschrift Fur Rheumatologie|July 22, 2024
[EULAR recommendations 2023 on the treatment of systemic lupus erythematosus -Implications for treatment in Germany]Johanna Mucke, Martin Aringer
Expert Review of Clinical Immunology|December 11, 2023
SLE criteria are by necessity still based on clinical (and immunological) criteria itemsMartin Aringer, Marta Mosca
Innere Medizin (Heidelberg, Germany)|August 4, 2022
[Anifrolumab in the treatment of systemic lupus erythematosus]Martin Aringer, Sirka Nitschmann
Wiener Medizinische Wochenschrift (1946)|November 21, 2014
[Biologics in SLE]Thomas Karonitsch, Martin Aringer
Arthritis Research & Therapy|January 26, 2013
Lots of autoantibodies equal lupus?Martin Aringer, Edward Vital
Zeitschrift Fur Rheumatologie|June 1, 2022
[Should HCQ be administered in SLE patients dependent on hemodialysis?]Martin Aringer, Christian Hugo
The Lancet. Rheumatology|June 14, 2024
For SLE activity and glucocorticoids: aim lowMartin Aringer, Jinoos Yazdany
Pageof 22

Showing results (11-20 of 216) with videos related to

Sort By:
Pageof 22
The Lancet. Rheumatology|January 30, 2024
Who will respond to type I interferon receptor blockade in SLE?Martin Aringer
Deutsche Medizinische Wochenschrift (1946)|March 30, 2016
[Systemic lupus erythematosus]Martin Aringer, Matthias Schneider
Deutsche Medizinische Wochenschrift (1946)|May 29, 2018
[Systemic Lupus Erythematosus (SLE) - New Classification Criteria]Martin Aringer, Thomas Dörner
Zeitschrift Fur Rheumatologie|July 22, 2024
[EULAR recommendations 2023 on the treatment of systemic lupus erythematosus -Implications for treatment in Germany]Johanna Mucke, Martin Aringer
Expert Review of Clinical Immunology|December 11, 2023
SLE criteria are by necessity still based on clinical (and immunological) criteria itemsMartin Aringer, Marta Mosca
Innere Medizin (Heidelberg, Germany)|August 4, 2022
[Anifrolumab in the treatment of systemic lupus erythematosus]Martin Aringer, Sirka Nitschmann
Wiener Medizinische Wochenschrift (1946)|November 21, 2014
[Biologics in SLE]Thomas Karonitsch, Martin Aringer
Arthritis Research & Therapy|January 26, 2013
Lots of autoantibodies equal lupus?Martin Aringer, Edward Vital
Zeitschrift Fur Rheumatologie|June 1, 2022
[Should HCQ be administered in SLE patients dependent on hemodialysis?]Martin Aringer, Christian Hugo
The Lancet. Rheumatology|June 14, 2024
For SLE activity and glucocorticoids: aim lowMartin Aringer, Jinoos Yazdany
Pageof 22